HnRNP E2 is downregulated in human oral cancer cells and the overexpression of hnRNP E2 induces apoptosis

Molecular Carcinogenesis

Volumn 46, Issue 3, 2007, Pages 198-207

  Roychoudhury, Paromita ^a   Paul, Ranjan Rashmi ^b,c   Chowdhury, Rajdeep ^a   Chaudhuri, Keya ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b DR R AHMED DENTAL COLLEGE AND HOSPITAL   (India)

^c Guru Nanak Institute of Dental Sciences and Research   (India)

Author keywords

Apoptosis; hnRNPE2; Oral squamous cell carcinoma; Real time quantitative RT PCR

Indexed keywords

ANNEXIN; BIOLOGICAL MARKER; CASPASE; GENE PRODUCT; PROPIDIUM IODIDE; PROTEIN HNRNP E2; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL NUCLEUS; CELL VIABILITY; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEAD AND NECK CANCER; HISTOLOGY; HISTOPATHOLOGY; HNRNP E2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MALE; MOUTH CANCER; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 33947117408     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20265     Document Type: Article

References (31)

1. Iwanaga K, Sueoka N, Sato A, Hayashi S, Sueoka E. Heterogeneous nuclear ribonucleoprotein B1 protein impairs DNA repair mediated through the inhibition of DNA-dependent protein kinase activity. Biochem Biophys Res Commun 2005;333:888-895.
2. Hay DC, Kemp GD, Dargemont C, Hay RT. Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription. Mol Cell Biol 2001;21:3482-3490.
3. Eversole A, Maizels N. In vitro properties of the conserved mammalian protein hnRNP D suggest a role in telomere maintenance. Mol Cell Biol 2000;20:5425-5432.
4. Ostrowski J, Kawata Y, Schullery DS, Denisenko ON, Bomsztyk K. Transient recruitment of the hnRNP K protein to inducibly transcribed gene loci. Nucleic Acids Res 2003;31: 3954-3962.
5. Kim JH, Paek KY, Choi K, et al. Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol Cell Biol 2003;23: 708-720.
6. Holcik M, Gordon BW, Korneluk RG. The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2. Mol Cell Biol 2003;23:280-288.
7. Bonnal S, Pileur F, Orsini C, et al. Heterogeneous nuclear ribonucleoprotein A1 is a novel internal ribosome entry site trans-acting factor that modulates alternative initiation of translation of the fibroblast growth factor 2 mRNA. J Biol Chem 2005;280:4144-4153.
8. de Hoog CL, Foster LJ, Mann M. RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers. Cell 2004;117:649-662.
9. Gibson TJ, Thompson JD, Heringa J. The KH domain occurs in a diverse set of RNA-binding proteins that include the antiterminator NusA and is probably involved in binding to nucleic acid. FEBS Lett 1993;324:361-366.
10. Makeyev AV, Chkheidze AN, Liebhaber SA. A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog. J Biol Chem 1999;274:24849-24857.
11. Leffers H, Dejgaard K, Celis JE. Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous(KH)domains. Eur J Biochem 1995;230: 447-453.
12. Perrotti D, Cesi V, Trotta R, et al. BCR-ABL suppresses C/ EBPalpha expression through inhibitory action of hnRNP E2. Nat Genet 2002;30:48-58.
13. Evans JR, Mitchell SA, Spriggs KA, et al. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 2003;22:8012-8020.
14. Pino I, Pio R, Toledo G, et al. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer 2003;41:131-143.
15. Ushigome M, Ubagai T, Fukuda H, et al. Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers. Int J Oncol 2005;26:635-640.
16. Zhou J, Allred DC, Avis I, et al. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 2001; 66:217-224.
17. Yan-Sanders Y, Hammons GJ, Lyn-Cook BD. Increased expression of heterogeneous nuclear ribonucleoprotein A2/ B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett 2002;183:215-220.
18. Fujiki H, Suganuma M, Okabe S, et al. Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat Res 2001;480-481:299-304.
19. Matsuyama S, Goto Y, Sueoka N, et al. Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis. Jpn J Cancer Res 2000;91:658-663.
20. Rauch J, Ahlemann M, Schaffrik M, et al. Allogenic antibody-mediated identification of head and neck cancer antigens. Biochem Biophys Res Commun 2004;323:156-162.
21. Goto Y, Sueoka E, Chiba H, Fujiki H. Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma. Jpn J Cancer Res 1999;90:1358-1363.
22. Shin KH, Kang MK, Kim RH, Christensen R, Park NH. Heterogeneous nuclear ribonucleoprotein G shows tumor suppressive effect against oral squamous cell carcinoma cells. Clin Cancer Res 2006;12:3222-3228.
23. Bidot P, Morgan M, Zhukov T, Tannenbaum M, Tockman MS. Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms. Endocr Pract 2001;7: 157-161.
24. Tani H, Ohshima K, Haraoka S, et al. Overexpression of heterogeneous nuclear ribonucleoprotein B1 in lymphoproliferative disorders: High expression in cells of follicular center origin. Int J Oncol 2002;21:957-963.
25. Pillai MR, Chacko P, Kesari LA, Jayaprakash PG, Jayaram HN, Antony AC. Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer. J Clin Pathol 2003;56:569-574.
26. Perrotti D, Calabretta B. Post-transcriptional mechanisms in BCR/ABL leukemogenesis: Role of shuttling RNA-binding proteins. Oncogene 2002;21:8577-8583.
27. Ausubel F, Brent MR, Kingston RE, et al. Current protocols in molecular biology. New York: John Willey and Sons.
28. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods 2001;25:386-401.
29. Verhaegen S, McGowan AJ, Brophy AR, Fernandes RS, Cotter TG. Inhibition of apoptosis by antioxidants in the human HL-60 leukemia cell line. Biochem Pharmacol 1995;50:1021-1029.
30. Du Z, Yu J, Chen Y, Andino R, James TL. Specific recognition of the C-rich strand of human telomeric DNA and the RNA template of human telomerase by the first KH domain of human poly(C)-binding protein-2. J Biol Chem 2004;279: 48126-48134.
31. Zhu J, Chen X. MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M. Mol Cell Biol 2000; 20:5602-5618.